NDC 73377-100-05 - Rifampin (Rifampicin)
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-100
- Requested NDC
- 73377-100-05
- Package NDCs from labels
- 73377-100-01, 73377-100-02, 73377-100-03, 73377-100-04, 73377-100-05, 73377-100-06
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-08-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rifampin (Rifampicin) - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-08-31 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-100-01 | Rifampin (Rifampicin) | 5 kg in 1 JAR | POWDER | 5 | 3 | |
| 73377-100-02 | Rifampin (Rifampicin) | 0.1 kg in 1 JAR | POWDER | 0.1 | 3 | |
| 73377-100-03 | Rifampin (Rifampicin) | 0.5 kg in 1 JAR | POWDER | 0.5 | 3 | |
| 73377-100-04 | Rifampin (Rifampicin) | 25 kg in 1 DRUM | POWDER | 25 | 3 | |
| 73377-100-05 | Rifampin (Rifampicin) | 1 kg in 1 JAR | POWDER | 1 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rifampin | RIFAMPIN | Mylan Institutional LLC | 8be91604-d7cd-4f2b-997d-e3364e4092e5 | 2026-05-05 | Warnings, Adverse reactions | VJT6J7R4TR |
| rifampin | RIFAMPIN | Bryant Ranch Prepack | 0cb75e95-d165-4580-9340-42d7a9fd546e | 2026-03-12 | Warnings, Adverse reactions | VJT6J7R4TR |
| rifampin | RIFAMPIN | Major Pharmaceuticals | 3f3534c1-95e4-4bdd-b044-9026e4addf0c | 2026-02-27 | Warnings, Adverse reactions | VJT6J7R4TR |
| rifampin | RIFAMPIN | Lupin Pharmaceuticals, Inc. | b56004f0-f23d-47f6-80c7-39884fccbccc | 2026-02-11 | Warnings, Adverse reactions | VJT6J7R4TR |
| rifampin | RIFAMPIN | A-S Medication Solutions | d53b6998-6e3b-4c6f-8465-2af6897d1efe | 2026-01-05 | Warnings, Adverse reactions | VJT6J7R4TR |
| RIFAMPIN | RIFAMPIN | Coupler LLC | 410a314f-83bf-d9b3-e063-6294a90a872c | 2025-10-13 | Warnings, Adverse reactions | VJT6J7R4TR |
| RIFAMPIN | RIFAMPIN | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 28109dee-3e5e-492b-b7d9-9ba46c0b5324 | 2025-03-25 | Warnings, Adverse reactions | VJT6J7R4TR |
| Rifampin | RIFAMPIN | ANI Pharmaceuticals, Inc. | b389b1a3-672f-47e3-916c-4a9c044b211b | 2024-10-10 | Warnings, Adverse reactions | VJT6J7R4TR |
| RIFAMPIN | RIFAMPIN | EPIC PHARMA, LLC | 0391f1e1-70d4-4b15-8b58-055bb6a385b8 | 2023-12-20 | Warnings, Adverse reactions | VJT6J7R4TR |
| Rifampin | RIFAMPIN | Chartwell RX, LLC | 4c39ee75-ae96-456d-bf47-16d49865345e | 2023-04-12 | Warnings, Adverse reactions | VJT6J7R4TR |
| Rifampin | RIFAMPIN | Fresenius Kabi USA, LLC | a1f9f1e2-dfc0-4d31-a13b-b656d897b791 | 2022-08-29 | Warnings, Adverse reactions | VJT6J7R4TR |
| Rifampin | RIFAMPIN | Hikma Pharmaceuticals USA Inc. | cb59a48c-f66b-4ea0-809c-de0e4be2f8c2 | 2022-01-28 | Warnings, Adverse reactions | VJT6J7R4TR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.